ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NBY NovaBay Pharmaceuticals Inc New

2.79
-0.19 (-6.38%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 120,621
Bid Price
Ask Price
News (2)
Day High 3.00

Low
0.065

52 Week Range

High
3.55

Day Low 2.71
Share Name Share Symbol Market Stock Type
NovaBay Pharmaceuticals Inc New NBY AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
-0.19 -6.38% 2.79 18:56:22
Open Price Low Price High Price Close Price Previous Close
3.00 2.71 3.00 2.71 2.98
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,885 120,621 US$ 2.83 US$ 341,208 - 0.065 - 3.55
Last Trade Type Quantity Price Currency
19:00:00 796 US$ 2.71 USD

NovaBay Pharmaceuticals Inc New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
18.09M 6.53M - 14.73M -16.7M -2.56 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NovaBay Pharmaceuticals News

Date Time Source News Article
6/07/202406:30Edgar (US Regulatory)Form 8-K - Current report
6/07/202405:50Business WireNovaBay Pharmaceuticals Plan of Compliance Accepted by the..
5/31/202415:50Edgar (US Regulatory)Form 8-K - Current report
5/31/202415:43Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]
5/30/202420:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202420:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202420:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202420:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202420:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:27Edgar (US Regulatory)Form 8-K - Current report
5/29/202416:22Business WireNovaBay Pharmaceuticals Announces Approval of All Proposals..
5/13/202407:30Business WireNovaBay Pharmaceuticals Launches Avenova Product Bundles for..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NBY Message Board. Create One! See More Posts on NBY Message Board See More Message Board Posts

Historical NBY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.353.552.703.13185,467-0.56-16.72%
1 Month0.08663.550.0750.148664724,733,5662.703,121.71%
3 Months0.1343.550.0650.13984199,821,5802.661,982.09%
6 Months0.303.550.0650.1469216,140,6272.49830.00%
1 Year0.623.550.0650.19777723,394,0542.17350.00%
3 Years25.196530.7020.0654.731,705,424-22.41-88.93%
5 Years11.55167.300.06524.492,125,959-8.76-75.84%

NovaBay Pharmaceuticals Description

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.